Intratio
Loading...
Skip to main content
Model output · Signal date Oct. 16, 2026

Daily SignalsNeutral

2760 companies scored · Total · absolute moveSwitch to Alpha · 30D 90D

Signal date 2026-10-16 Cut-offs from the 2026-10-16 run
Companies scored 2760 IC ≥ 0 · market cap ≥ $100M
Median forecast +2.41% Total · 90D
Long–short spread +6.43% Strong Buy minus Strong Sell, mean
Median IC 0.27 Spearman · 90D
Rating changes ▲ 165 ▼ 380 vs the previous run
Cross-section

Distribution of the day's forecasts

90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Signals · Neutral

53 companies

Sorted by 90D forecast ↓

# Ticker Sector IC Mkt cap Rating 30D 90D Δ
1 RYTMRHYTHM PHARMACEUTICALS, INC. Life Sciences 0.23 $6.1B Neutral +1.16% +3.33% ·
2 CYRXCryoport, Inc. Life Sciences 0.29 $853M Neutral +1.04% +3.27% ·
3 ACBAURORA CANNABIS INC Life Sciences 0.16 $253M Neutral +1.09% +3.26% ▼ 1
4 WVEWave Life Sciences, Inc. Life Sciences 0.18 $629M Neutral +1.10% +3.26% ·
5 ACOGAlpha Cognition Inc. Life Sciences 0.62 $184M Neutral +1.12% +3.24% ▼ 1
6 TRLVTrulieve Cannabis Corp. Life Sciences 0.56 $2.0B Neutral +1.12% +3.24% ▼ 1
7 ASNDAscendis Pharma A/S Life Sciences 0.00 $14.8B Neutral +1.19% +3.21% ▼ 1
8 PTCTPTC THERAPEUTICS, INC. Life Sciences 0.12 $5.1B Neutral +1.15% +3.18% ▼ 1
9 VNDAVanda Pharmaceuticals Inc. Life Sciences 0.28 $256M Neutral +1.13% +3.16% ·
10 ANABANAPTYSBIO, INC Life Sciences 0.27 $1.4B Neutral +1.11% +3.15% ·
11 TLXTelix Pharmaceuticals Ltd Life Sciences 0.15 $3.6B Neutral +1.07% +3.13% ▼ 1
12 GMABGENMAB A/S Life Sciences 0.02 $23.8B Neutral +1.08% +3.11% ·
13 RGENREPLIGEN CORP Life Sciences 0.62 $10.4B Neutral +1.01% +3.10% ·
14 KROSKeros Therapeutics, Inc. Life Sciences 0.15 $211M Neutral +1.00% +3.03% ·
15 NRIXNurix Therapeutics, Inc. Life Sciences 0.27 $2.5B Neutral +0.97% +3.01% ·
16 NBPNovaBridge Biosciences Life Sciences 0.18 $145M Neutral +0.90% +3.00% ·
17 MGTXMeiraGTx Holdings plc Life Sciences 0.31 $891M Neutral +0.87% +2.94% ·
18 AMRXAmneal Pharmaceuticals, Inc. Life Sciences 0.48 $6.1B Neutral +1.02% +2.91% ·
19 BBIOBridgeBio Pharma, Inc. Life Sciences 0.08 $13.0B Neutral +0.93% +2.87% ·
20 OMEROMEROS CORP Life Sciences 0.15 $1.4B Neutral +0.81% +2.81% ·
21 HRMYHarmony Biosciences Holdings, Inc. Life Sciences 0.49 $2.2B Neutral +0.99% +2.78% ·
22 VTVTvTv Therapeutics Inc. Life Sciences 0.14 $342M Neutral +0.88% +2.78% ▼ 1
23 SABSSAB Biotherapeutics, Inc. Life Sciences 0.15 $236M Neutral +0.87% +2.76% ·
24 SIGASIGA TECHNOLOGIES INC Life Sciences 0.47 $229M Neutral +0.94% +2.73% ·
25 BHCBausch Health Companies Inc. Life Sciences 0.51 $2.4B Neutral +0.84% +2.68% ·
26 CGENCOMPUGEN LTD Life Sciences 0.31 $197M Neutral +0.77% +2.67% ·
27 NIKANIKA PHARMACEUTICALS, INC Life Sciences 0.17 $431M Neutral -0.80% +2.67% new
28 NAGENiagen Bioscience, Inc. Life Sciences 0.59 $197M Neutral +0.77% +2.65% ·
29 HCMHUTCHMED (China) Ltd Life Sciences 0.14 $2.5B Neutral +0.85% +2.62% ·
30 TGTXTG THERAPEUTICS, INC. Life Sciences 0.43 $8.9B Neutral +0.88% +2.58% ·
31 SUPNSUPERNUS PHARMACEUTICALS, INC. Life Sciences 0.10 $2.3B Neutral +0.86% +2.55% ▼ 1
32 AGIOAGIOS PHARMACEUTICALS, INC. Life Sciences 0.14 $1.9B Neutral +0.87% +2.52% ·
33 INDPIndaptus Therapeutics, Inc. Life Sciences 0.09 $380M Neutral +0.70% +2.51% ▲ 1
34 IPHAInnate Pharma SA Life Sciences 0.15 $139M Neutral +0.71% +2.50% ▼ 1
35 AMRNAMARIN CORP PLC\UK Life Sciences 0.05 $238M Neutral +0.85% +2.46% ·
36 RIGLRIGEL PHARMACEUTICALS INC Life Sciences 0.05 $883M Neutral +0.75% +2.43% ·
37 INSMINSMED Inc Life Sciences 0.43 $21.0B Neutral +0.78% +2.37% ·
38 MRKMerck & Co., Inc. Life Sciences 0.21 $360.1B Neutral +0.85% +2.37% ▲ 1
39 TLRYTilray Brands, Inc. Life Sciences 0.15 $437M Neutral +0.67% +2.37% ·
40 HALOHALOZYME THERAPEUTICS, INC. Life Sciences 0.31 $13.8B Neutral +0.76% +2.34% ·
41 ARDXARDELYX, INC. Life Sciences 0.39 $770M Neutral +0.68% +2.30% ·
42 MSLESatellos Bioscience Inc. Life Sciences 0.52 $146M Neutral +0.64% +2.29% ·
43 VRDNViridian Therapeutics, Inc.\DE Life Sciences 0.46 $2.2B Neutral +0.67% +2.29% ▼ 1
44 KRYSKrystal Biotech, Inc. Life Sciences 0.18 $9.4B Neutral +0.67% +2.24% ·
45 ALNYALNYLAM PHARMACEUTICALS, INC. Life Sciences 0.56 $31.0B Neutral +0.71% +2.22% ·
46 CRMDCorMedix Inc. Life Sciences 0.18 $566M Neutral +0.61% +2.19% ·
47 COAGHemab Therapeutics Holdings, Inc. Life Sciences 0.46 $1.4B Neutral +0.61% +2.18% ·
48 QGENQIAGEN N.V. Life Sciences 0.18 $10.0B Neutral +0.69% +2.18% ·
49 RPRXRoyalty Pharma plc Life Sciences 0.28 $26.3B Neutral +0.69% +2.11% ·
50 LKFTLakefront Biotherapeutics NV Life Sciences 0.38 $2.0B Neutral +0.60% +2.07% ·
1–50 of 53 Previous Next
Since the previous run

Rating changes

▲ 165▼ 380
Which companies were upgraded or downgraded is part of the paid plans.
Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account
Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-16) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected absolute price move over the horizon, market included. This is the number a price target is built from. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.